Table 2.
Characteristics and risk factors of patients with BCS and SVT
| BCS (n = 14) | SVT (n = 20) | P 1 | |
| Age: Median (IQR) | 39.5 (27.25) yr | 42.5 (20.5) yr | 0.18 |
| Female | 21.4% | 40% | 0.30 |
| Acute presentation | 21.4% | 40% | 0.30 |
| Hereditary risk factors | 35.7% | 25% | 0.70 |
| Factor V Leyden mutation | 14.3% | 10% | 0.55 |
| Prothrombin gene mutation | 0% | 0% | - |
| Homozygous MTHFR gene mutation | 0% | 0% | - |
| Protein C deficiency | 7.1% | 10% | 1.0 |
| Protein S deficiency | 0% | 0% | - |
| AT III deficiency | 21.4% | 5% | 0.28 |
| Acquired risk factors | 7.1% | 45% | 0.02 |
| No risk factor | 57.1% | 45% | 0.70 |
1
Fisher’s exact test for categorical variables and Mann Whitney’s U test for continuous variable.